Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

9.47
Delayed Data
As of Sep 01
 -0.1575 / -1.64%
Today’s Change
4.83
Today|||52-Week Range
12.75
+41.77%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 15.75, with a high estimate of 16.10 and a low estimate of 13.00. The median estimate represents a +66.31% increase from the last price of 9.47.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.46
Sales
$5.2M
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.46%
 
 
 
 
 
 
Growthannually -6.82%
 
 
 
 
 

Sales

Growthquarterly 23.60%
 
 
 
 
 
 
Growthannually 99.29%
 
 
 
 
 
Key to the earnings and sales forecast charts.